These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34878838)

  • 1. TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection.
    Wu Y; Wang M; Yin H; Ming S; Li X; Jiang G; Liu Y; Wang P; Zhou G; Liu L; Gong S; Zhou H; Shan H; Huang X
    Sci Adv; 2021 Dec; 7(50):eabi6802. PubMed ID: 34878838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM-2 promotes Th1 responses by interacting with the CD3ζ-ZAP70 complex following Mycobacterium tuberculosis infection.
    Wu Y; Wu M; Ming S; Zhan X; Hu S; Li X; Yin H; Cao C; Liu J; Li J; Wu Z; Zhou J; Liu L; Gong S; He D; Huang X
    J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein PGLYRP1/Tag7 Peptides Decrease the Proinflammatory Response in Human Blood Cells and Mouse Model of Diffuse Alveolar Damage of Lung through Blockage of the TREM-1 and TNFR1 Receptors.
    Sharapova TN; Romanova EA; Chernov AS; Minakov AN; Kazakov VA; Kudriaeva AA; Belogurov AA; Ivanova OK; Gabibov AG; Telegin GB; Yashin DV; Sashchenko LP
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
    Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
    J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation.
    Shilagardi K; Spear ED; Abraham R; Griffin DE; Michaelis S
    mBio; 2022 Oct; 13(5):e0254322. PubMed ID: 36197088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
    Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
    J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced Pluripotent Stem Cells Regulate Triggering Receptor Expressed on Myeloid Cell-1 Expression and the p38 Mitogen-Activated Protein Kinase Pathway in Endotoxin-Induced Acute Lung Injury.
    Su VY; Yang KY; Chiou SH; Chen NJ; Mo MH; Lin CS; Wang CT
    Stem Cells; 2019 May; 37(5):631-639. PubMed ID: 30681755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.
    Chen J; Lau YF; Lamirande EW; Paddock CD; Bartlett JH; Zaki SR; Subbarao K
    J Virol; 2010 Feb; 84(3):1289-301. PubMed ID: 19906920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infection.
    Hassebroek AM; Sooryanarain H; Heffron CL; Hawks SA; LeRoith T; Cecere TE; Stone WB; Walter D; Mahsoub HM; Wang B; Tian D; Ivester HM; Allen IC; Auguste AJ; Duggal NK; Zhang C; Meng XJ
    J Med Virol; 2023 Feb; 95(2):e28503. PubMed ID: 36655751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
    Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
    mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
    Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
    mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
    Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
    J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
    Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Cordón PJ; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2022; 13():995235. PubMed ID: 36172368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
    Iwata-Yoshikawa N; Okamura T; Shimizu Y; Hasegawa H; Takeda M; Nagata N
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of DAP12 and molecules associated with DAP12 during host responses to mycobacterial infection.
    Aoki N; Zganiacz A; Margetts P; Xing Z
    Infect Immun; 2004 May; 72(5):2477-83. PubMed ID: 15102754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of triggering receptor expressed on myeloid cells-1 (TREM-1) in COVID-19 and other viral pneumonias: a systematic review and meta-analysis of clinical studies.
    de Oliveira YLM; de Sá Resende A; Martins-Filho PR; de Moura TR
    Inflammopharmacology; 2022 Jun; 30(3):1037-1045. PubMed ID: 35347523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study.
    Molodtsov IA; Kegeles E; Mitin AN; Mityaeva O; Musatova OE; Panova AE; Pashenkov MV; Peshkova IO; Alsalloum A; Asaad W; Budikhina AS; Deryabin AS; Dolzhikova IV; Filimonova IN; Gracheva AN; Ivanova OI; Kizilova A; Komogorova VV; Komova A; Kompantseva NI; Kucheryavykh E; Lagutkin DА; Lomakin YA; Maleeva AV; Maryukhnich EV; Mohammad A; Murugin VV; Murugina NE; Navoikova A; Nikonova MF; Ovchinnikova LA; Panarina Y; Pinegina NV; Potashnikova DM; Romanova EV; Saidova AA; Sakr N; Samoilova AG; Serdyuk Y; Shakirova NT; Sharova NI; Sheetikov SA; Shemetova AF; Shevkova LV; Shpektor AV; Trufanova A; Tvorogova AV; Ukrainskaya VM; Vinokurov AS; Vorobyeva DA; Zornikova KV; Efimov GA; Khaitov MR; Kofiadi IA; Komissarov AA; Logunov DY; Naigovzina NB; Rubtsov YP; Vasilyeva IA; Volchkov P; Vasilieva E
    Clin Infect Dis; 2022 Aug; 75(1):e1-e9. PubMed ID: 35435222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
    Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
    J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.